Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Κύριοι συγγραφείς: | Mukhtyar, C, Luqmani, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2007
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2008) -
Eular recommendations for vasculitis
ανά: Luqmani, R, κ.ά.
Έκδοση: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2009)